急性基底动脉闭塞血管内治疗后恶性脑水肿的发生率、预测因素与结局:ATTENTION试验的二次分析
本文为ATTENTION试验的事后分析,纳入中国36个中心189例接受血管内治疗的急性基底动脉闭塞患者,回顾性评估Jauss评分≥4分定义的恶性脑水肿。13.2%患者发生恶性脑水肿,基线GCS评分(OR 0.722, 95%CI 0.548-0.950; p=0.020)和操作次数(OR 1.594, 95%CI 1.051-2.419; p=0.028)为预测因素,恶性脑水肿与90天功能独立率低、良好结局率低及死亡率高显著相关。
要点
- 基底动脉闭塞血管内治疗后恶性脑水肿发生率为13.2%。
- 基线GCS评分越高,恶性脑水肿风险越低(OR 0.722)。
- 操作次数越多,恶性脑水肿风险越高(OR 1.594)。
核心结论
- 恶性脑水肿在接受血管内治疗的基底动脉闭塞患者中并不少见,且与不良结局相关。
- 基线GCS评分和操作次数是恶性脑水肿的预测因素。
- 作者认为,临床实践中识别血管内治疗后的恶性脑水肿对选择适当的药物治疗策略和密切监测至关重要。
研究设计与样本
- ATTENTION试验的事后分析;ATTENTION为前瞻性、随机、多中心临床试验,比较血管内治疗与常规治疗,在中国36个中心纳入基底动脉闭塞患者。
- 共分析189例患者,采用Jauss评分回顾性评估所有可用随访影像,Jauss评分≥4分定义为恶性脑水肿。
- 功能独立定义为90天随访时改良Rankin量表(mRS)评分0-2分,良好结局定义为mRS评分0-3分。
- 采用单因素和多因素分析探讨恶性脑水肿的预测因素及其对预后的影响。
主要发现
- 189例患者中13.2%发生恶性脑水肿。
- 多因素分析显示基线GCS评分(OR 0.722, 95%CI 0.548-0.950; p=0.020)和操作次数(OR 1.594, 95%CI 1.051-2.419; p=0.028)与恶性脑水肿显著相关。
- 校正混杂因素后,恶性脑水肿与90天随访时较低的功能独立率(OR 0.115, 95%CI 0.023-0.563; p=0.008)、较低的良好结局率(OR 0.092, 95%CI 0.023-0.360; p=0.001)和较高的死亡率(OR 5.373, 95%CI 2.055-14.052; p=0.001)显著相关。
关键数值与推荐
- 恶性脑水肿定义:Jauss评分≥4分。
- 功能独立定义:90天随访时mRS评分0-2分。
- 良好结局定义:90天随访时mRS评分0-3分。
临床怎么用
- 作者认为,临床实践中识别血管内治疗后的恶性脑水肿对选择适当的药物治疗策略和密切监测至关重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Malignant cerebral edema (MCE) is a life-threatening complication of ischemic stroke. Few studies have evaluated MCE in patients with acute basilar artery occlusion (BAO) receiving endovascular treatment (EVT). Therefore, the authors investigated the incidence, predictors, and functional outcomes of MCE in BAO patients undergoing EVT. METHODS: This was a post hoc analysis of the Endovascular Treatment for Acute Basilar Artery Occlusion (ATTENTION) trial, a prospective, randomized, multicenter clinical trial that compared endovascular treatment with conventional care of patients with BAO at 36 centers in China. Brain edema was retrospectively assessed using the Jauss score for all available follow-up scans, and patients with a Jauss score ≥ 4 were classified as having MCE. Clinical functional independence was defined as a modified Rankin Scale (mRS) score of 0-2, and a good outcome was defined as an mRS score of 0-3 at the 90-day follow-up. Univariate and multivariate analyses were used to explore the predictors of MCE and the impact of MCE on prognosis. RESULTS: A total of 189 patients were analyzed, and 13.2% of patients developed MCE. Multivariate analysis showed that the baseline Glasgow Coma Scale (GCS) score (OR 0.722, 95% CI 0.548-0.950; p = 0.020) and the number of procedures (OR 1.594, 95% CI 1.051-2.419; p = 0.028) were significantly associated with MCE. After adjusting for confounding factors, the presence of MCE was significantly associated with a lower rate of functional independence (OR 0.115, 95% CI 0.023-0.563; p = 0.008), a lower rate of good outcome (OR 0.092, 95% CI 0.023-0.360; p = 0.001), and a higher rate of mortality (OR 5.373, 95% CI 2.055-14.052; p = 0.001) at the 90-day follow-up. CONCLUSIONS: MCE is not uncommon in BAO patients undergoing EVT and is associated with poor outcomes. Baseline GCS score and the number of procedures were predictors of MCE. In clinical practice, it is crucial that physicians identifying MCE after EVT in patients with BAO and identification of MCE will help in the selection of an appropriate pharmacological treatment strategy and close monitoring.
引用
- Huang X, Wang H, Ji Y, et al. Incidence, predictors, and outcomes of malignant cerebral edema in acute basilar artery occlusion after endovascular treatment: a secondary analysis of the ATTENTION trial. J Neurosurg. 2024. PMID: 38579342. doi:10.3171/2024.1.JNS232085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。